QMS • Primary Packaging

Primary Packaging Regulatory Consultant

Get your primary packaging right the first time — material selection, extractables and leachables, container closure integrity, stability and the ISO 15378 system behind it, for pharma and medical-device products.

Service Overview

Primary packaging is the part of the pack in direct contact with the product — the vial, ampoule, stopper, syringe, blister, bottle or closure — and it does far more work than it looks. It has to protect the product from moisture, oxygen, light and contamination, it must not interact with the formulation in ways that harm it, and it has to maintain its integrity over the whole shelf life. When primary packaging is chosen or qualified badly, the consequences show up late and expensively: failed stability, regulatory queries, recalls, or a container that leaks sterility. Getting it right early is enormously cheaper than fixing it late.

The decisions start with materials. Glass type, rubber formulation, plastic resin, coating and closure design all carry trade-offs between protection, compatibility, cost and manufacturability. A choice that seems fine on paper can turn out to leach into the product, adsorb the active ingredient, or fail to hold a seal, and by the time stability data reveals it you have lost months. We help make these choices with the downstream evidence requirements in view, so the material you select is one you can actually defend.

Two technical areas dominate the regulatory conversation around primary packaging: extractables and leachables, and container closure integrity. Regulators want assurance that nothing harmful migrates from the packaging into the product, and that the container maintains a barrier — particularly for sterile and injectable products where a breach is a patient-safety issue. These are specialist studies with real subtlety, and they are exactly where under-prepared submissions attract difficult questions.

Primary packaging also has to earn its shelf-life claim. The stability program that establishes how long a product lasts is, in large part, a test of the packaging as much as the formulation, and the storage conditions on the label have to be ones the pack genuinely supports. A packaging choice that cannot hold up under Indian climatic conditions, or that was validated against the wrong zone, undermines the whole stability story. We make sure the packaging and the stability claim are consistent.

Behind all of this sits the quality system. For packaging manufacturers, that means ISO 15378; for pharma and device companies, it means the controls in your own ISO 13485 or GMP system that govern how packaging is specified, qualified and released. Primary packaging is not a standalone project — it threads through material science, regulatory evidence and quality management at once, which is why it benefits from a consultant who sees all three.

We support you across the whole primary-packaging lifecycle: material selection and supplier qualification, extractables and leachables and container closure integrity studies, stability alignment, regulatory documentation, and the quality-system controls that hold it together — so the packaging decision is one that stands up in your dossier and in the field.

Packaging material selection with compatibility and cost trade-offs assessed
Extractables and leachables (E&L) study design and interpretation
Container closure integrity (CCI) strategy and method selection
Stability alignment so the pack supports its shelf-life claim
Supplier qualification and ISO 15378 alignment
Regulatory documentation that defends the packaging choice

Key Takeaways

  • Primary packaging touches the product directly, so its material, extractables and barrier properties are a regulatory concern in their own right.
  • The wrong pack choice surfaces late — as a stability failure — which is the most expensive time to find it.
  • Material selection, supplier qualification and compatibility studies are where this work earns its keep.

The Real Job of Primary Packaging

It is tempting to treat packaging as an afterthought once the product works, but primary packaging is a functional part of the product’s safety and stability. It provides the barrier that keeps moisture, oxygen and light out and sterility in; it must be compatible with the formulation so it neither contaminates it nor absorbs it; and it has to keep doing both for the entire shelf life under real storage and transport conditions. A failure in any of these is a failure of the product, not merely of the pack.

Because these demands pull in different directions — better barrier can mean higher cost, a more inert material can be harder to process — packaging is a genuine engineering decision that deserves proper attention. We frame it that way from the start, weighing protection, compatibility, integrity, cost and manufacturability together, so the choice is deliberate rather than defaulted to whatever was used last time or whatever the supplier had in stock.

  • Barrier: protection from moisture, oxygen, light and contamination.
  • Compatibility: no harmful interaction with the formulation.
  • Integrity: maintaining the barrier across the full shelf life.

Choosing Materials You Can Defend

Material selection is where the whole packaging story is set, and where the most expensive mistakes are made. Glass comes in types with different chemical resistance; elastomeric closures vary enormously in their formulation and their tendency to leach or adsorb; plastics differ in permeability and in what they can give off. A material chosen for cost or availability, without regard to compatibility, can quietly undermine a product and only reveal itself in stability or in an E&L study months later.

We help you choose with the evidence requirements already in mind — selecting materials whose compatibility and safety you will be able to demonstrate, from suppliers who can support the qualification. That foresight is what prevents the classic trap of committing to a material, building around it, and then discovering during studies that it cannot be defended. Choosing for defensibility, not just performance, is the discipline that saves projects.

Extractables and Leachables

Extractables and leachables — E&L — is the study of what can migrate from the packaging into the product. Extractables are what can be forced out of the material under exaggerated conditions; leachables are what actually migrates into the product under real conditions over shelf life. Regulators, especially for injectables and inhalation products, want assurance that these migrants are identified and shown to be safe at the levels present. Done poorly, E&L is a rich source of difficult regulatory questions.

We help design E&L studies that are proportionate to the product’s risk, select appropriate testing partners, and interpret the results in the regulatory context — distinguishing a genuine safety concern from a harmless trace, and building the toxicological rationale where needed. The aim is an E&L package that answers the regulator’s question convincingly the first time rather than triggering a spiral of follow-up queries about unidentified peaks.

Container Closure Integrity

Container closure integrity — CCI — is about whether the pack maintains its barrier, and for sterile products it is a patient-safety issue: a container that loses integrity can lose sterility. Regulators have moved towards deterministic CCI methods over the older probabilistic ones like dye ingress, and choosing the right method for your product and container is a real technical decision. A CCI strategy that relies on a weak method, or that does not cover the whole shelf life and the stresses of distribution, is an easy target for a reviewer.

We help you build a CCI strategy that fits the product and the container closure system, select and where necessary validate appropriate methods, and integrate CCI into stability so integrity is demonstrated across shelf life rather than just at release. For sterile and injectable products this is not a box-ticking exercise; it is central to the product’s safety story, and we treat it with the seriousness it deserves.

  • CCI proves the container maintains its barrier — critical for sterility.
  • Deterministic methods are increasingly expected over dye ingress.
  • Integrity must be shown across shelf life and distribution stresses.

Packaging and the Stability Story

A shelf-life claim is only as good as the packaging that supports it. The stability program that establishes how long a product lasts is run in the actual packaging, under defined climatic conditions, and the storage statement on the label has to reflect what the pack genuinely supports. For the Indian market, that means testing under the appropriate climatic zone — hotter and more humid than temperate conditions — and a packaging choice that quietly fails to protect under those conditions takes the shelf-life claim down with it.

We make sure the packaging decision and the stability strategy are joined up: that the pack is qualified for the conditions it will actually face, that the stability protocol tests the right things, and that the shelf-life and storage claims are ones the data can defend. Discovering a packaging-driven stability failure late is one of the most expensive setbacks in product development, and it is almost always preventable with the packaging and stability plans built together.

Suppliers, Quality Systems and Documentation

A good packaging decision has to be supported by a supply chain and a quality system that keep it honest. That means qualifying packaging suppliers properly — ideally suppliers who themselves hold ISO 15378 — controlling changes to packaging specifications, and holding the release and traceability records that prove each batch of packaging met spec. A perfect material choice undermined by an uncontrolled supplier or an undocumented change is no better than a poor choice.

We help you build the supplier qualification, change control and documentation around your packaging so it stays defensible over time, and we make sure the regulatory documentation — the packaging specifications, the qualification and study reports, the justification of your choices — is complete and coherent in your dossier. Regulators read the packaging section of a submission carefully, and a well-organised, well-justified packaging story is one less place for the review to snag.

Why Packaging Problems Surface Late — and How to Prevent It

The cruel thing about primary packaging is that its failures are usually invisible at the start and painful at the end. A marginal material choice looks fine until stability data at nine months shows degradation; a weak seal passes at release and fails after transport; an unidentified leachable surfaces in a regulatory review after the product is otherwise ready to file. By then the cost of change — reformulating studies, re-running stability, re-filing — is enormous, and the launch slips with it.

Preventing this is almost entirely about front-loading the thinking: choosing defensible materials, designing E&L and CCI studies early, aligning packaging with stability from the outset, and controlling the supply chain. That is exactly where an experienced primary-packaging consultant earns their fee — not in heroics at the end, but in the unglamorous foresight at the start that means the packaging simply never becomes the problem that derails the project. We bring that foresight so your packaging is a solved question, not a lurking risk.

Required Documentation

Packaging Material Specifications
Compatibility / Material Selection Rationale
Extractables & Leachables Reports
Container Closure Integrity Data
Stability Data in Final Pack
Supplier Qualification Records
Packaging Change Control Records
Regulatory Packaging Documentation

"Accurate documentation is 70% of the battle. Our experts pre-audit every file before submission."

Our Delivery Workflow

01

Material Strategy

We assess the product and select defensible packaging materials and suppliers with the evidence in view.

02

E&L & CCI

We design and interpret extractables/leachables and container closure integrity studies.

03

Stability Alignment

We align the packaging with the stability program so the pack supports its shelf-life claim.

04

Document & Control

We build the documentation, supplier qualification and change control that keep the choice defensible.

FAQ

Frequently Asked Questions

Have questions? Find direct, humanized answers about the regulatory approvals and timelines.

Primary packaging is the part of the pack in direct contact with the product — the vial, ampoule, stopper, syringe, blister, bottle or closure. It protects the product, must be compatible with it, and has to maintain its integrity over the whole shelf life.
Extractables are substances that can be forced out of packaging materials under exaggerated conditions; leachables are what actually migrates into the product under real conditions over shelf life. Regulators want assurance these migrants are identified and safe, especially for injectables and inhalation products.
Container closure integrity (CCI) is whether the pack maintains its barrier. For sterile products it is a patient-safety matter, because a loss of integrity can mean a loss of sterility. Regulators increasingly expect deterministic CCI methods demonstrated across shelf life.
The stability program that sets shelf life is run in the actual packaging, so the pack’s barrier and compatibility directly determine how long the product lasts. A packaging choice that fails to protect under real conditions — including India’s hot, humid climatic zone — undermines the shelf-life claim.

Launch Your Product In Record Time

Red tape shouldn't decide your launch date. We keep the paperwork moving and the queries answered, so approvals come through sooner.

Start My Application
Compliant With 2024 Amendments